Thyrocare Technologies Limited (THYROCARE.NS) NSE

1,210.20

+86(+7.65%)

Updated at September 29 02:48PM

Currency In INR

Thyrocare Technologies Limited

Address

D/37-3, TTC Industrial Area

Navi Mumbai, 400703

India

Phone

91 22 4125 2525

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

1693

First IPO Date

May 10, 2016

Key Executives

NameTitlePayYear Born
Mr. Rahul Franklin GuhaMD, Chief Executive Officer & Chairman35M1978
Ms. Preet KaurVice President of Lab Operations & Quality01983
Mr. Aditya ShindeVice President01989
Mr. Alok Kumar JagnaniChief Financial Officer0N/A
Mr. K. KallathiKumarChief Operating Officer0N/A
Mr. Nitin ChughChief Commercial Officer0N/A
Mr. Pratik HireHead of Strategy & Investor Relations0N/A
Mr. Brijesh KumarCompany Secretary & Compliance Officer0N/A
Mr. Kapil GuptaStrategy Manager0N/A

Description

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.